Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Diana Ferraro MD, PhD

Diana Ferraro MD, PhD

Neurologist, Multiple Sclerosis Centre and Neuroimmunology Laboratory, University of Biomedical, Metabolic and Neurosciences; University of Modena and Reggio Emilia, Modena, Italy

Diana Ferraro is currently a researcher in Neurology at the Department of Biomedical, Metabolic and Neurosciences of the University of Modena and Reggio Emilia (Modena, Italy) and a Neurology consultant in the Neurology Unit of the Azienda Ospedaliero Universitaria of Modena, Italy.

Her main clinical and research interests are focused on Multiple Sclerosis and, in particular, on clinical issues and on the study of biological markers of diagnosis and prognosis.  

She is involved in teaching activity (Medicine and Surgery, Dietetics, Nursing and Biotechnology students) and is a member of the Faculty Board of the Neuroscience Doctorate of the University of Modena and Reggio Emilia.

She collaborates with national and international research groups and registries (“MSBase Neuroimmunology Registry”, Italian MS Registry, RIREMS -“Rising Researchers in Multiple Sclerosis”) and is Associate Editor of “BMC Neurology”.

She has authored or co-authored over 85 published papers.


Dr. Ferraro has received travel grants, research support or speaker honoraria from Merck-Serono, Biogen, Genzyme, Novartis, TEVA, Roche, and Binding Site.

Recent Contributions to PracticeUpdate:

  1. Clinical Significance of a Single CSF Immunoglobulin Band